Receiving treatment at a specialist centre confers an overall survival benefit for patients with mantle cell lymphoma
Sign Up to like & getrecommendations! Published in 2019 at "British Journal of Haematology"
DOI: 10.1111/bjh.15696
Abstract: Recent clinical advances in mantle cell lymphoma (MCL) have seen standard-of-care treatment algorithms transformed. Frontline rituximab combination therapy, high dose cytarabine-based induction in younger patients and, more recently, Bruton Tyrosine Kinase (BTK) inhibitors in the… read more here.
Keywords: specialist centre; treatment; mantle cell; treatment specialist ... See more keywords